Neurotrophic factor therapy for nervous system degenerative diseases

Journal of Neurobiology

Volumn 25, Issue 11, 1994, Pages 1418-1435

  Hefti, Franz ^a  

^a GENENTECH INC   (United States)

Author keywords

Alzheimer's disease; neurodegeneration; neurodegenerative disease; neuropharmacology; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG ANALOG; GROWTH FACTOR; K 252A; K 252B; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEURITE PROMOTING FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; NEUROTROPIC AGENT; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFERRIN RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN INJURY; DRUG CONJUGATION; DRUG SELECTIVITY; HUNTINGTON CHOREA; INTRACEREBRAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOTOR NEURON DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SENSORY NEUROPATHY; SPINAL CORD INJURY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; HUMAN; NERVE DEGENERATION; NERVE GROWTH FACTORS; NERVOUS SYSTEM DISEASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027972153     PISSN: 00223034     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/neu.480251109     Document Type: Article

References (193)

1. Transplantation of polymer encapsulated neurotransmitter secreting cells: effect of the encapsulation technique
2. Parkinson's disease: pathophysiology
3. Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture
4. Brain‐derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo
5. Effects of astrocytes insulin and insulin‐like growth factor I on the survival of motoneurons in vitro
6. Nerve growth factor prevents toxic neuropathy in mice
7. Nerve growth factor prevents experimental cisplatin neuropathy
8. Effects of administration of ciliary neurotrophic factor on normal motor and sensory peripheal nerves in vivo
9. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines
10. Differential expression of two members of FGF receptor gene family, FGFR‐1 and FGFR‐2 mRNA, in the adult rat central nervous system. Mol.
11. Fibroblast growth factors
12. Receptor‐ and heparin‐binding domains of basic fibroblast growth factor
13. Use of central neuronal cultures for the detection of neuronotrophic agents
14. BcI‐2 affects survival but not neuronal differentiation of PC12 cells
15. Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human
16. Pretreatment of dopaminergic neurons in culture with brain‐derived neurotrophic factor attenuates toxicity of 1‐methy1‐4‐pyridinium
17. The nature of the trophic action of brain‐derived neurotrophic factor, des(1–3)‐ insulin‐like growth factor‐1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture
18. Neurotrophic effect of naturally occurring long‐chain fatty alcohols on cultured CNS Neurons
19. Nerve growth factor revisited
20. Functional nerve growth factor receptors on human B lymphocytes
21. Induction of NGF by isoproterenol, 4‐methylcatechol and serum occurs by three distinct mechanisms. Mol.
22. Neurotrophic receptors: a window into neuronal differentiation
23. Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat
24. Ciliary neurotrophic factor prevents retrograde neuronal death the adult central nervous system
25. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis
26. Mice lacking nerve growth factor display loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons
27. Electrophysiologic study in peripheral neuropathy associated with HIV infection
28. BFGF promotes the survival of entorhinal layer II neurons after perforant path axotomy
29. Structural and functional identification of regualtory regions and cis elements surrounding the nerve growth factor gene promoter. Mol.
30. MPTP‐treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF)
31. Doody, R. S., and Tacrine Collaborative Study Group. A. double‐blind, placebo‐controlled multicenter study of tacrine for Alzheimer's diases
32. Delayed treatment with nerve growth factor improves acquision of a spatial task in rats with lesions of the nucleus basalis magnocellularis: evaluation of the involvement of different neurotransmitter systems
33. Markesbery, W. R. and the Intraventricular Bethancechol Study Group. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations
34. Nerve growth factor facilitates regeneration across never gaps: morphological and behavioral studies in rat sciatic dnerve
35. The physiology of transforming growth factor alpha
36. Sensory nerves in adult rats regenerate and restore sensory function to the skin independently of endogenous NGF
37. Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat
38. Tacrine in Alzheimer's disease
39. Functional and evolution in the NGF family and its receptors
40. Transient expression of NGF‐receptor‐like immmunoreactivity in postnatal rat brain and spinal cord
41. Inhibition of epidermal growth factor/transforming growth factor‐alpha‐stimulated cell growth by a synthetic peptide
42. Expression of nerve growth factor receptor mRNA is developmentally regulated and increased after axotomy in rat spinal cord motoneurons
43. Expression of mRNAs for neurotrophin receptors in the dorsal root ganglion and spinal cord during development and following peripheral or central axotomy. Mol.
44. Characterization of bovine heparin‐binding neurotrophic factor (HBNF): assignment of disulfide bonds
45. Nerve growth factor mRNA content parallels altered sympathetic innervation in the spontaneously hypertensive rat
46. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family
47. A controlled trial of tacrine in Alzheimer's disease
48. Basic Fibroblast Growth Factor promotes the survival and development of mesencephalic neurons in culture
49. Amelioration of cholinergic neurons atrophy and spatial memory impairment in aged rats by nerve growth factor
50. NGF improves spatial memory in aged rodents as a function of age
51. Neurochemical studies of early‐onset Alzheimer's disease. Possible influence on treatment
52. Blood–brain barrier penetration and In vivo activity of an NGF conjugate
53. Differential actions of neurotrophins in the locus coeruleus and basal forebrain
54. Neutrophic sesquiterpene‐neoligans from Magnolia obovata: structure and neurotrophic activity
55. Nerve growth factor‐induced synaptogenesis and hypertrophy of cortical chlinergic terminals
56. Different binding epitopes on the NK1 receptor for substance P and non‐peptide and antagonist
57. Effects of esatrogen and fimbria/fornix transection on p75NGFR and ChAT expression in the medial septum and diagonal band of Broca
58. A role for IGF‐1 in the rescue of CNS neurons following hypoxic‐ichemic injury
59. Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. Mol.
60. Experimental autoimmune model of nerve growth factor deprivation: effects on developing peripheral sympathetic and sensory neurons
61. Interleukin‐6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two‐week‐old rats in cultures
62. Neurotrophin gene expression by cells lines derived form human giomas
63. Intracerebroventricular bethanechol chloride infusion in Alzheimer's disease: results of a collaborative double blind study
64. Attenuation of nucleus basalis of Meynert lesion‐induced cholinergic deficits by nerve growth factor
65. Nerve growth factor (NGF) promotes survival of septal cholinergic neurons after fimbrial transections
66. Rationale for the planned chinical trials with nerve growth factor in Alzheimer's disease
67. Chronic intraventricular injections of nerve growth factor elevated hippocampal choline acetyltransferase activity in adult rats with partial septo‐hippocampal lesion
68. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neuro‐degenerative deseases
69. Neurotrophins promote motor neuron survival and are present in embryonic limb bud
70. Changes of nerve growth factor synthesis in non‐neuronal cells in response to sciatic nerve transection
71. NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a Fimbria‐Fornix lesion
72. Identification and characterization of a novel member of the nerve growth factor/brain‐derived neurotrophic factor family
73. Identification of heregulin, a specific activator of p185erbB2
74. p140trk mRNA marks NGF‐responsive forebrain neurons: evidence tht trk gene expression is induced by NGF
75. Evidence that fibroblast growth factor 5 is a major muscle‐derived survival factor for culture spinal motoneurons
76. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
77. Structure‐fuction studies of nerve growth factor: functional importance of highly conserved amino acid residues
78. The alpha component of the CNTF receptor is required for signaling and defines potential CNTF targets in the adult and during development
79. Intacerabral NGF infusion induces hyperinnervation of cerebral blood vessels
80. Relationship of insulin‐like growth factor II gene expression in muscle to synaptogenesis
81. Long‐term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway
82. Interleukin 3 as a tropic fator for central cholinergic neurons in vitro and in vivo
83. Influences of neuronatal and adult exposures to testosterone on the levels of the betasubunit of nerve growth factor in the neural tissues of mice
84. Heircenones C. D and E., stimulators of nerve growth factor (NGF) and E., stimulators of nerve growth factor (NGF)‐synthesis, from the mushroom Hericium erinaceu
85. K‐252 compounds: modulators of neurotrophin signal transduction
86. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, and the insulin‐like growth factors
87. Promotion of central cholinergic and dopaminergic neuron differentiation by brain‐derived neurotrophic factor but not neurotrophin‐3
88. Brain‐derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes afer axotomy in the adult rat brain
89. K‐25b selectively potentiates cellular actions and trk tyrosine phosphorylation mediated by neurotrophin‐3
90. Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat
91. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates
92. Evidence that brain‐derived neurotrophic factor is a trophic factor for motor neurons in vivo
93. Fragments of bovine insulin‐like growth factors I and II stimulate proliferation of rat L6 myoblast cells
94. Trophic effect of erythropoietin and other hemotopoietic factors on central cholinergic neurons in vitro and in vivo
95. Alzheimer's disease: a cell biological perspective
96. Interleukin‐6 as a neurotrophic factor for promoting the survival of cultured catecholaminerergic neurons in a chemically defined medium from fetal and postnatal rat midbrains
97. Chronic intranigral administration of brain‐derived neurotophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection
98. 125I] nerve growth factor in the rat brain following and intraventricular injection: sequestration by trk A mRNA expressing septal neurons
99. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease
100. Nerve growth factor and nociception
101. Nerve growth factor‐induced hyperalgesia in the neonatal and adult rat
102. Purification and characterization of glia maturation factor beta: a growth regulator for neurons and glia
103. Purification, cloning, and expression of ciliary neurotrophic factor (CNTF)
104. GDNF: a glial cell line‐derived neurotrophic factor for midbrain dopaminergic neurons
105. Glucocorticoid hormones negatively regulate nerve growth factor expression In vivo and in cultured rat fibroblasts
106. Beta‐nerve growth factor influences the expression of androgen‐binding protein messenger ribonucleic acid in rat testis
107. Ehk‐1 and Ehk‐2: two novel members of the Eph receptor‐like tyrosine kinase famely with distinctive structures and neuronal expression
108. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system
109. Parkinson's disease
110. Transforming Growth Factor Beta 1 is a potent survival factor for tat embryo motoneurons in culture
111. Disruption of the CNTF gene results in motor neuron degeneration
112. Basic fibroblast growth factor ameliorates rotational behavior of substantia nigral‐ transplanted rats with lesions of the dopaminergic nigrostriatal neurons
113. Microencapsulated nerve growth factor: effects on the forebrain neurons following devascularizing cortical lesions
114. Nerve growth factor induces mast cell degranulation without changing intracellualr calcium levels
115. Apparent anterograde transport of basic fibroblast growth factor in the rat nigrostriatal dopamine system
116. Expression and co‐expression of trk receptors in subpopulations of adult primary sensory neurons projection to identified peripheral targets
117. Enhanced synthesis of brain‐derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA
118. Induction of apoptosis in fibroblasts by IL‐1ß‐converting enzyme, a mammalian homolog of the C. elegans cell death Geneced‐3
119. Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesion
120. Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions
121. Nerve growth factor induces gene expression for prion‐ and Alzheimer's beta‐amyloid proteins
122. Cisplatin neurotoxicity
123. Basic fibroblast growth factor and epidermal growth factor exert differntial trophic effects on CNS neurons
124. Plasminogen promotes the development of rat mesencephalic dopaminergic neurons in vitro
125. Association between high levels of expression of the trk gene and favorable outcome in human neuroblastoma
126. Insulin‐like growth factor II stimulates motor nerve regeneration
127. Inhibition of the cellular actions of nerve growth factor by stauroporine and K‐252a results from the attenuation of the activity of the trk tyrosine kinase
128. Effect of growth factors and cytokines on expression of amyloid beta protein precursor mRNAs in cultured neural cells. Mol.
129. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease: one year follow up
130. Nerve growth factor affects 11C‐nicotine binding, blood flow, EEG and verbal episodic memory in an Alzheimer patient
131. Control of embryonic motoneuron survival in vivo by cilliary neurotrophic factor
132. Brain‐derived neurotrophic factor rescues developing avian motoneurons from cell death
133. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP‐treated mice
134. +: specificity and impact of culture conditions. non‐dopaminergic neurons, and astroglial cells
135. Transnasal and intraventricular delivery of drugs
136. +)‐damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF
137. 1, 1, 3Tricyano‐2‐amino‐1‐propene (Triap) stimulates choline acetyl‐transferase activity in vitro and in vivo
138. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
139. New perspective on Alzheimer's disease
140. Effects of insulin, insulin‐like growth factor‐II and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons
141. Immunolocalization of ciliary neuronotrophic factor in adult rat sciatic nerve
142. Nerve growth factor enhances regeneration through silicone chambers
143. Cu/Zn superoxide dismutse activity in familial and sporadic amyotrophic lateral sclerosis
144. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
145. Grafting genetically modified cells to the damaged brain: restorative effects on NGF expression
146. Motor neuron diseases and amyotrophic lateral sclerosis
147. Motor neuron diseases and amyotrophic lateral sclerosis: research progress
148. Regional and cell‐specific expression of GDNF in rat brain
149. Neurotrophin‐3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion
150. Ciliary neurotrophic factor prevents degeneration of motor neurons after axotomy
151. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy
152. Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration
153. Brain‐derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section
154. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor
155. Indentification of the functional regualatory region of the neurotrophic‐3 gene promotor. Mol.
156. Insulin‐like growth factor (IGF‐I) as a stimulator of regeneration in the freeze‐injured rat sciatic nerve
157. Brain‐derived neurotrophic factor protects dopamine neurons against 6‐hydroxydompamine and N‐methyl‐4‐phenylpyridinium ion toxicity: involvement of the glutathione system
158. Transforming growth factor‐beta: recent progress and new challenges
159. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: Comparison between the effects of interleukin‐1 and various growthfactors in astrocyte cultures and in vivo
160. Localization of acidic fibroblast growth factor in specific subcortical neuronal populations
161. Regional distribution, developmental changes, and cellular localization of CNTF‐mRNA and protein in the rat brain
162. Glial cell line‐derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo
163. NGF/BDNF chimeric proteins: analysis of neurotrophin specificity by homolog‐scanning mutagenesis
164. Stimulation of nerve growth factor synthesis/secretion by 1,4 benxoquinone and its derivatives in cultured mouse astroglial cells
165. Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppression by axonal contact, and binding properties
166. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors
167. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery
168. Radial‐maze deficits produced by colchicine administered into the area of the nucleus basalis are ameliorated by cholinergic agents
169. High molecular weight basic fibroblast growth factor‐like protein is localized to a subpopulation of mesencephalic dopaminergic neurons in the rat brain
170. Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease
171. Estrogen receptors colocalize with low‐affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain
172. Rising spirits for motor neuron revival
173. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain
174. Messenger RNAs for trk and the low‐affinity NGF receptor in rat basal forebrain
175. Colocalization of NGF binding sites, trk mRNA, and low‐affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF
176. Basal forebrain lesions in monkeys disrupt attention but not learning and memory
177. Fibroblast growth factor promotes survival survival of dissociated hippocampal neurons and enhances neurite extension
178. Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization
179. Clinical observations and experiments in diabetic neuropathy
180. Chemoattractant agents and nerve growth factor stimulate human spermatozoal reactive oxygen species generation
181. Down‐regulation of phosphatidylinositol response to BDNF and NT‐3 in cultures of cortical neurons
182. Behavioral and neurochemical effects of chronic intracentricular injections of nerve growth factor in adult rats with fimbria lesions
183. Hypophagia is induced by intracerebroventricular administration of nerve growth factor
184. Continuous infusion of nerve growth factor prevents basal fore brain neuronal death after fimbria fornix transection
185. Neurotrophic factors promote the maturation of developing sensory neurons before they become dependent on these factors for survival
186. Basic fibroblast growth factor prevents thalamuc degeneration after cortical infarction
187. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor
188. OPC‐21268, an orally effective, nonpeptide vasopression V1 receptor antagonist
189. Brain‐derived neurotrophic factor spinal motor neurons from axotomy‐induced cell death
190. Midkine, a novel neurotrophic factor is present in senile plaques of Alzheimer's disease
191. Chronic nerve growth factor treatment of normaotensive rats